Phase 1 Hepatitis B Trial, Recruiting (NCT06671093)

Phase 1 Hepatitis B Trial, Recruiting NCT06671093 Sponsor: Tune Therapeutics, Inc. Condition: Hepatitis B

Printed from Voxsanity (voxsanity.com.au) — NCT06671093 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hepatitis B

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are male or female, between 18 and 75 years old (inclusive)
Your body weight is in a healthy or higher range (BMI of 18.5 or above) at the time of screening
You have been diagnosed with Chronic Hepatitis B
You are currently taking antiviral medication known as a nucleos(t)ide analogue to treat Hepatitis B
You may be either HBeAg-negative or HBeAg-positive (a marker found in the blood related to Hepatitis B — confirm with trial site if unsure which you are)

Who may not be able to join:

Your liver enzyme levels (ALT/AST) and a substance called bilirubin in your blood are both significantly above the normal range (confirm with trial site for exact values)
You have any signs or history of liver disease caused by something other than the Hepatitis B virus
There may be additional requirements not listed here, as further eligibility rules set by the trial organisers could apply (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06671093

Sponsor: Tune Therapeutics, Inc.

Phase: Phase 1

Status: Recruiting

Condition: Hepatitis B

More information: https://clinicaltrials.gov/study/NCT06671093

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are male or female, between 18 and 75 years old (inclusive)
Your body weight is in a healthy or higher range (BMI of 18.5 or above) at the time of screening
You have been diagnosed with Chronic Hepatitis B
You are currently taking antiviral medication known as a nucleos(t)ide analogue to treat Hepatitis B
You may be either HBeAg-negative or HBeAg-positive (a marker found in the blood related to Hepatitis B — confirm with trial site if unsure which you are)

Who may not be able to join:

Your liver enzyme levels (ALT/AST) and a substance called bilirubin in your blood are both significantly above the normal range (confirm with trial site for exact values)
You have any signs or history of liver disease caused by something other than the Hepatitis B virus
There may be additional requirements not listed here, as further eligibility rules set by the trial organisers could apply (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

Tune Therapeutics, Inc.

Registry

ClinicalTrials.gov

Start date

29 November 2024

Est. completion

28 June 2028

Where this trial is recruiting

Hong Kong Moldova 🇳🇿 New Zealand

Primary endpoints

Safety as assessed by treatment emergent adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov